EP3965728A1 - Odermennigextrakt als umweltfreundliches mittel - Google Patents
Odermennigextrakt als umweltfreundliches mittelInfo
- Publication number
- EP3965728A1 EP3965728A1 EP20722610.1A EP20722610A EP3965728A1 EP 3965728 A1 EP3965728 A1 EP 3965728A1 EP 20722610 A EP20722610 A EP 20722610A EP 3965728 A1 EP3965728 A1 EP 3965728A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- extract
- skin
- agrimony
- aerial parts
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 85
- 244000307697 Agrimonia eupatoria Species 0.000 title claims abstract description 72
- 235000000125 common agrimony Nutrition 0.000 title claims abstract description 60
- 239000000203 mixture Substances 0.000 claims abstract description 57
- 239000002537 cosmetic Substances 0.000 claims abstract description 39
- 230000000694 effects Effects 0.000 claims description 34
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 claims description 30
- 239000003344 environmental pollutant Substances 0.000 claims description 23
- 231100000719 pollutant Toxicity 0.000 claims description 23
- 230000008591 skin barrier function Effects 0.000 claims description 18
- 230000007613 environmental effect Effects 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 11
- 241000196324 Embryophyta Species 0.000 claims description 9
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 9
- 230000000699 topical effect Effects 0.000 claims description 8
- 235000016626 Agrimonia eupatoria Nutrition 0.000 claims description 6
- 230000009471 action Effects 0.000 claims description 6
- 230000002265 prevention Effects 0.000 claims description 4
- 230000035807 sensation Effects 0.000 claims description 3
- 208000003251 Pruritus Diseases 0.000 claims description 2
- 230000018044 dehydration Effects 0.000 claims description 2
- 238000006297 dehydration reaction Methods 0.000 claims description 2
- 230000007803 itching Effects 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 238000012986 modification Methods 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 7
- 210000003491 skin Anatomy 0.000 description 53
- 238000000605 extraction Methods 0.000 description 19
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 17
- 239000002904 solvent Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 12
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 10
- 230000006378 damage Effects 0.000 description 9
- 208000035475 disorder Diseases 0.000 description 9
- 210000002615 epidermis Anatomy 0.000 description 9
- 210000004209 hair Anatomy 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 230000035882 stress Effects 0.000 description 8
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 230000005855 radiation Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 6
- 235000008777 kaempferol Nutrition 0.000 description 6
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 230000036620 skin dryness Effects 0.000 description 6
- 239000012855 volatile organic compound Substances 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 230000036542 oxidative stress Effects 0.000 description 5
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 206010001488 Aggression Diseases 0.000 description 4
- 241000208125 Nicotiana Species 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 4
- 230000016571 aggressive behavior Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- -1 cyclic chemical compounds Chemical class 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000003859 lipid peroxidation Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000779 smoke Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 3
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 3
- 239000000809 air pollutant Substances 0.000 description 3
- 231100001243 air pollutant Toxicity 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000002485 combustion reaction Methods 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 3
- 235000009498 luteolin Nutrition 0.000 description 3
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000003642 reactive oxygen metabolite Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 2
- 241001164374 Calyx Species 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010012438 Dermatitis atopic Diseases 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 229920002079 Ellagic acid Polymers 0.000 description 2
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 244000062730 Melissa officinalis Species 0.000 description 2
- 235000010654 Melissa officinalis Nutrition 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010040830 Skin discomfort Diseases 0.000 description 2
- OXVUXGFZHDKYLS-BLIWDXROSA-N Tormentic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@](O)(C)[C@H]5C4=CC[C@@H]3[C@]21C OXVUXGFZHDKYLS-BLIWDXROSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000003915 air pollution Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 2
- 235000008714 apigenin Nutrition 0.000 description 2
- 229940117893 apigenin Drugs 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 229960002852 ellagic acid Drugs 0.000 description 2
- 235000004132 ellagic acid Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 239000000865 liniment Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N methyl pentane Natural products CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000005949 ozonolysis reaction Methods 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N quercetin Natural products C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 229910052815 sulfur oxide Inorganic materials 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- VULLSLYDWNGNKZ-UHFFFAOYSA-N 12319Tetrahydroxyurs-12-en-28-oic acid Natural products OC1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)C(O)(C)C5C4=CCC3C21C VULLSLYDWNGNKZ-UHFFFAOYSA-N 0.000 description 1
- XCHZVKNZDNVOLO-UHFFFAOYSA-N 19alpha-Hydroxy-ursolic-acid Natural products CC1CCC2(CCC3(C)C(=CCC4C3(C)CCC5C(C)(C)C(O)CCC45CO)C2C1C)C(=O)O XCHZVKNZDNVOLO-UHFFFAOYSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N 3-methyl-2-pentanone Chemical compound CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- IVCZEZUJCMWBBR-UHFFFAOYSA-N 7-O-beta-D-glucopyranosyl-7,3',4'-trihydroxyflavone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 IVCZEZUJCMWBBR-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 235000016993 Agrimonia Nutrition 0.000 description 1
- KMOUJOKENFFTPU-UHFFFAOYSA-N Apigenin-7-glucosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=CC(O)=CC=3)OC2=C1 KMOUJOKENFFTPU-UHFFFAOYSA-N 0.000 description 1
- TXVHTIQJNYSSKO-UHFFFAOYSA-N BeP Natural products C1=CC=C2C3=CC=CC=C3C3=CC=CC4=CC=C1C2=C34 TXVHTIQJNYSSKO-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- KGEKLUUHTZCSIP-HOSYDEDBSA-N Bornyl acetate Natural products C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000157855 Cinchona Species 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 101800004637 Communis Proteins 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 238000007064 Criegee rearrangement reaction Methods 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010019049 Hair texture abnormal Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 101001050321 Homo sapiens Junctional adhesion molecule C Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- OXVUXGFZHDKYLS-UHFFFAOYSA-N Jacarandic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)C(O)(C)C5C4=CCC3C21C OXVUXGFZHDKYLS-UHFFFAOYSA-N 0.000 description 1
- 102100023429 Junctional adhesion molecule C Human genes 0.000 description 1
- VSUOKLTVXQRUSG-UHFFFAOYSA-N Lgr Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 VSUOKLTVXQRUSG-UHFFFAOYSA-N 0.000 description 1
- VSUOKLTVXQRUSG-ZFORQUDYSA-N Luteolin 7-O-beta-D-glucuronide Natural products O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 VSUOKLTVXQRUSG-ZFORQUDYSA-N 0.000 description 1
- DBCOQZCHOPRYAK-UHFFFAOYSA-N Luteolin-7-O-Glucuronid Natural products OC1OC(C(O)C(O)C1O)C(=O)Oc2cc(O)c3C(=O)C=C(Oc3c2)c4ccc(O)c(O)c4 DBCOQZCHOPRYAK-UHFFFAOYSA-N 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 208000017657 Menopausal disease Diseases 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 229910002089 NOx Inorganic materials 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- YPWHZCPMOQGCDQ-UHFFFAOYSA-N Populnin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=CC(O)=CC=3)OC2=C1 YPWHZCPMOQGCDQ-UHFFFAOYSA-N 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- NSZQOXBBEWYGQH-UHFFFAOYSA-N Quercetin-3-rhamnosid Natural products CC1OC(O)C(O)C(OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C1O NSZQOXBBEWYGQH-UHFFFAOYSA-N 0.000 description 1
- QJTYCCFDQWFJHU-UHFFFAOYSA-N Quercetin-5-O-beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC2=C1C(=O)C(O)=C(C=1C=C(O)C(O)=CC=1)O2 QJTYCCFDQWFJHU-UHFFFAOYSA-N 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241001262105 Sargassum muticum Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 241000287219 Serinus canaria Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- CRPUJAZIXJMDBK-UHFFFAOYSA-N Toxaphene Natural products C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 1
- HOUHSBKVSRPPGO-UHFFFAOYSA-N UNPD177615 Natural products OCC(O)C1OC(OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)cc4)C(O)C1O HOUHSBKVSRPPGO-UHFFFAOYSA-N 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- SOSLMHZOJATCCP-PADPQNGGSA-N afzelin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1)C1=C(c2ccc(O)cc2)Oc2c(c(O)cc(O)c2)C1=O SOSLMHZOJATCCP-PADPQNGGSA-N 0.000 description 1
- PPFLXOUHEPKYMK-UHFFFAOYSA-N agrimoniin Natural products Oc1cc2C(=O)OCC3OC(OC(=O)c4cc(O)c(O)c(Oc5cc(C(=O)OC6OC7COC(=O)c8cc(O)c(O)c(O)c8c9c(O)c(O)c(O)cc9C(=O)OC7C%10OC(=O)c%11cc(O)c(O)c(O)c%11c%12c(O)c(O)c(O)cc%12C(=O)OC6%10)c(O)c(O)c5O)c4)C%13OC(=O)c%14cc(O)c(O)c(O)c%14c%15c(O)c(O)c(O)cc%15C(=O)OC%13C3OC(=O)c%16cc(O)c(O)c(O)c%16c2c(O)c1O PPFLXOUHEPKYMK-UHFFFAOYSA-N 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- HQNOUCSPWAGQND-UHFFFAOYSA-N alpha-Rhamnoisorobin Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=CC(O)=CC=3)OC2=C1 HQNOUCSPWAGQND-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- LFYKLMBWGAMUQU-UHFFFAOYSA-N apigenin 7-O-glucuronide Natural products OC1OC(C(O)C(O)C1O)C(=O)Oc2cc(O)c3C(=O)C=C(Oc3c2)c4ccc(O)cc4 LFYKLMBWGAMUQU-UHFFFAOYSA-N 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000037365 barrier function of the epidermis Effects 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N beta-linalool Natural products CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- 229940115397 bornyl acetate Drugs 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229940026455 cedrol Drugs 0.000 description 1
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 description 1
- 230000006567 cellular energy metabolism Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- NGSWKAQJJWESNS-UHFFFAOYSA-N cis-para-coumaric acid Natural products OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 229930193997 cynaroside Natural products 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001968 ellagitannin Polymers 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- BZAFROBDXRJYTQ-UHFFFAOYSA-N euscaphinin Natural products OC1=C(O)C(O)=CC(C(=O)OC2C3OC(=O)C4=CC(O)=C(O)C(O)=C4C4=C(O)C(O)=C(O)C=C4C(=O)OC3C3OC(=O)C4=CC(O)=C(O)C(O)=C4C4=C(O)C(O)=C(O)C=C4C(=O)OCC3O2)=C1OC(C(=C(O)C=1)O)=CC=1C(=O)OC1OC2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C2C1OC(=O)C1=CC(O)=C(O)C(O)=C1C1=C(O)C(O)=C(O)C=C1C(=O)O2 BZAFROBDXRJYTQ-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 229920002824 gallotannin Polymers 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 239000000399 hydroalcoholic extract Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- OVSQVDMCBVZWGM-QCKGUQPXSA-N isoquercetin Natural products OC[C@@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O OVSQVDMCBVZWGM-QCKGUQPXSA-N 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- MYXNWGACZJSMBT-VJXVFPJBSA-N isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O MYXNWGACZJSMBT-VJXVFPJBSA-N 0.000 description 1
- OYJCWTROZCNWAA-UHFFFAOYSA-N isovitexin Natural products OCC1OC(C(O)C(O)C1O)c2c(O)cc3CC(=CC(=O)c3c2O)c4ccc(O)cc4 OYJCWTROZCNWAA-UHFFFAOYSA-N 0.000 description 1
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- ZZZILDYSXRHUNY-UHFFFAOYSA-N kaempferol-3-O-glucoside Natural products OC1OC(COC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)cc4)C(O)C(O)C1O ZZZILDYSXRHUNY-UHFFFAOYSA-N 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 150000002634 lipophilic molecules Chemical class 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- PEFNSGRTCBGNAN-QNDFHXLGSA-N luteolin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-QNDFHXLGSA-N 0.000 description 1
- QZOVLVSTWSTHQN-UHFFFAOYSA-N luteolin 7-O-glucoside Natural products OCC1OC(Oc2cc(O)c3C(=O)C=C(C(=O)c3c2)c4ccc(O)c(O)c4)C(O)C(O)C1O QZOVLVSTWSTHQN-UHFFFAOYSA-N 0.000 description 1
- KBGKQZVCLWKUDQ-UHFFFAOYSA-N luteolin-glucoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC2=C1C(=O)C=C(C=1C=C(O)C(O)=CC=1)O2 KBGKQZVCLWKUDQ-UHFFFAOYSA-N 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 229940118019 malondialdehyde Drugs 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- PEFNSGRTCBGNAN-UHFFFAOYSA-N nephrocizin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-UHFFFAOYSA-N 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- DVGGLGXQSFURLP-FIZCXTQCSA-N potengriffioside A Natural products O[C@@H]1[C@@H](COC(=O)C=Cc2ccc(O)cc2)O[C@@H](Oc2c(oc3cc(O)cc(O)c3c2=O)-c2ccc(O)cc2)[C@H](O)[C@H]1O DVGGLGXQSFURLP-FIZCXTQCSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- LUGRJXSUUSMJEB-UHFFFAOYSA-N quercetin 3-O-rhamnoside Natural products OC1C(O)C(O)C(C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1 LUGRJXSUUSMJEB-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- SZDMSNWMQAMVTJ-UHFFFAOYSA-N quercetin-3-O-glucoside Natural products OC1OC(COC2=C(C(=O)c3cc(O)cc(O)c3O2)c4ccc(O)c(O)c4)C(O)C(O)C1O SZDMSNWMQAMVTJ-UHFFFAOYSA-N 0.000 description 1
- FZKBNCDAGYDHTP-UHFFFAOYSA-N quercetin-3-O-glycoside Natural products OC1C(O)C(O)C(O)OC1COC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O FZKBNCDAGYDHTP-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- 125000003410 quininyl group Chemical group 0.000 description 1
- GGHMUJBZYLPWFD-UHFFFAOYSA-N rac-patchouli alcohol Natural products C1CC2(C)C3(O)CCC(C)C2CC1C3(C)C GGHMUJBZYLPWFD-UHFFFAOYSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000001104 scent gland Anatomy 0.000 description 1
- JBFOLLJCGUCDQP-UHFFFAOYSA-N scutellarin A Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC1=CC(O)=C2C(=O)C=C(C=3C=CC(O)=CC=3)OC2=C1 JBFOLLJCGUCDQP-UHFFFAOYSA-N 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- XTQHKBHJIVJGKJ-UHFFFAOYSA-N sulfur monoxide Chemical class S=O XTQHKBHJIVJGKJ-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229920001864 tannin Chemical group 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Chemical group 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- LTRRTGCXRIMDTF-UHFFFAOYSA-N tiliroside Natural products OC1C(COC(=O)C=Cc2ccc(O)cc2)OC(OC3=C(Oc4cc(O)cc(O)c4C3)c5ccc(O)c(O)c5)C(O)C1O LTRRTGCXRIMDTF-UHFFFAOYSA-N 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- DVGGLGXQSFURLP-VWMSDXGPSA-N tribuloside Chemical compound C([C@@H]1[C@H]([C@@H]([C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1)O)O)OC(=O)\C=C\C1=CC=C(O)C=C1 DVGGLGXQSFURLP-VWMSDXGPSA-N 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 201000002282 venous insufficiency Diseases 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Definitions
- TITLE Agrimony extract as an anti-pollution agent
- the present invention relates to an extract of agrimony and to compositions containing this extract for an application in the field of cosmetics and dermatology for combating the harmful effects of pollution on the skin.
- the official definition of pollution is "a degradation of the environment by the introduction into the air, water or soil of materials not naturally present in the environment".
- air pollution continues to increase, mainly due to human activity, measures have been put in place to give priority to research aimed at reducing or controlling emissions of polluting gases.
- the consequences of this atmospheric pollution not only have effects on a planetary scale such as the greenhouse effect and the destruction of the ozone layer, but also on a local level on health, well-being, skin and the dander of living beings.
- the main pollutants have natural and anthropogenic origins.
- particulates also called suspended particles and tobacco smoke.
- the effect of these polluting factors on the skin is amplified when combined with other pollutants and / or solar radiation.
- UV rays associated with pollutants, cause an increase in free radicals and lipid peroxidation.
- Blue light emitted by the sun and by certain devices with fluorescent or D.e.l. lighting (computer, tablet, television, laptop), would have an influence on photo-aging. Its spectrum varies between 380 and 500 nm, so its rays are those among visible radiation that have the highest energy. Blue light would increase the rate of internal free radicals and the production of melanin, thus promoting the formation of pigment spots.
- PAHs come from, among other things, the combustion of wood and organic matter as well as exhaust gases. They can settle and / or adsorb on the surface of particulate matter. PAHs can enter the skin via hair follicles or through the epidermis. They are converted into quinines, cyclic chemical compounds that produce reactive oxygen species. They can also promote acne. Among the PAHs we find 2,3,7,8-tetrachlorodibenzo-p-dioxin, a halogenated aromatic hydrocarbon, which is a lipophilic compound capable of activating the aromatic hydrocarbon receptor, which will activate the oxidative cascade (Drakaki et al. al., 2014).
- Volatile organic compounds come from organic solvents contained in paints, varnishes, lacquers, fuels, tobacco smoke, emissions industrial and automotive. Studies have shown that these compounds induce an increase in cytokines which promote the development of inflammatory and allergic reactions such as atopic dermatitis and psoriasis. The combined action of volatile organic compounds, hydrocarbons, nitrogen oxides, and sunlight can lead to the formation of ozone (Drakaki et al., 2014).
- Ozone can have a natural origin since it is released in small quantities by the soil and plants. However, it is mainly of anthropogenic origin. Ozone is a strong oxidizing agent capable of altering the integrity of the skin. In the skin, it induces oxidative stress and lipid peroxidation, respectively it decreases the concentration of antioxidant vitamins C and E and increases the concentration of malondialdehyde (MD A). It acts preferentially on the lipids and fatty acids constituting the lipid matrix of the horny layer of the epidermis, in which it will form reactive oxygen species. These processes will upset the balance of the epidermis and lead to multiple skin disorders via stimulation of
- MMPs which, in turn, will degrade the collagen and elastin fibers of the dermis, accelerating skin aging, tissue sagging and ultimately deepening wrinkles (Drakaki et al., 2014).
- the oxides are mainly nitrogen dioxide, sulfur dioxide and carbon monoxide which are involved in skin damage.
- Nitrogen dioxide is of anthropogenic origin since it is emitted during combustion.
- Sulfur dioxide can have the same origin as nitrogen dioxide, but also a natural origin linked to forest fires and volcanic eruptions.
- Carbon monoxide comes from incomplete combustions. In areas where these oxides are present in high concentrations, there is an increase in atopic dermatitis in children according to studies conducted in Europe (Drakaki et al., 2014).
- Airborne particles are fine solid particles carried by air or water. It is not the particles themselves which are responsible for the deleterious effects but the molecules adsorbed on these particles (benzo (a) pyrene, heavy metals, pesticides ). They can generate oxidative stress on the skin and are thus at least partly responsible for skin aging. They are believed to induce the formation of wrinkles and the appearance of pigment spots.
- pollution has an effect on reducing the protective barrier function of the skin by modifying the hydrolipidic film. It will cause an alteration of the
- patent application WO06111666 which discloses a composition containing an extract of Camellia sinensis and an extract of Lampsana communis for combating the cutaneous consequences of pollution.
- patent FR 2838342 which relates to cosmetic compositions containing an extract of seaweed
- Sargassum muticum useful in combating the consequences of oxidative stress induced by reactive oxygen species, ultraviolet radiation and against the effects of pollution.
- Kostryco et al (World Scientific News 89 (2017) 90-97) describe that an extract of agrimony has anti-inflammatory properties. This document certainly mentions the anti-inflammatory properties of an agrimony extract, but such an effect is cited among many other virtues.
- Kostryco et al thus make an inventory of the phytotherapeutic properties (point 5 page 93) of agrimony extracts and cite an anti-HBV activity, an anti-influenza activity, an antibacterial activity, an activity on the healing of wounds, an activity antioxidant which they bind to an anti-inflammatory activity and in particular at the level of the gastrointestinal mucosa, an anti -diarrheal activity, an anti-cancer activity.
- This document cites thus mixes the weakness of the organism, epigastric pain, intestinal inflammation, hepatic disorders, digestive, enteric and gastric disorders but also cholecystitis, flatulence, varicose veins, damaged skin, baths mouth, pharyngitis, respiratory inflammation, asthma, menopausal disorders, protection of cardiovascular disorders, gynecological disorders, diabetes-related problems and pathologies of the urinary sphere.
- This document therefore focuses on digestive inflammation but does not mention dermatological or cosmetic effects.
- the skin cells, their lipids and proteins, but also their DNA are the targets of pollutants, which generate oxidation and inflammation.
- Dull, dry, reactive and / or sensitive skin, acne, premature and accelerated aging, are, among others, the identified consequences of pollution.
- This pollution therefore leads to an overproduction of free radicals in the skin, which disrupt the skin's balance and accelerate aging.
- UV rays or tobacco pollution is therefore an additional risk factor.
- the skin in particular the upper layer of the epidermis, constitutes a barrier against external aggressions such as chemical, mechanical or infectious and against environmental factors (climate, ultraviolet rays, pollutants and / or xenobiotics).
- This property is mainly provided by the outermost layer of the epidermis, namely the horny layer.
- stratum corneum One of the functions of the stratum corneum is to absorb and retain the water contained in the epidermis, and any alteration in its structure and / or function can lead to changes in the hydration of the skin and more particularly an increase in water loss. Excessive dry skin can, through a vicious circle, lead to impaired skin barrier function, and increased stress damage. environmental.
- a skin barrier disorder can be generally defined as a condition in which the skin, or more particularly the epidermis and in particular the stratum corneum, does not exhibit a normal barrier function. This deterioration of the skin may simply be a minor aesthetic alteration and / or a sensation of skin discomfort or skin dryness. Thus, despite a few options currently available, consumers are in need of new compounds or compositions useful in combating the harmful effects of pollution on the skin, skin tone, skin texture and skin firmness as well as on the hair.
- an extract of agrimony in particular of its aerial parts, more particularly the flowering tops, made it possible to protect the skin and integuments as well as keratin materials against the harmful effects of pollution. (example 2).
- the invention therefore relates to a new use of an agrimony extract as an anti-pollution cosmetic agent, as well as the use of anti-pollution cosmetic compositions containing this extract.
- the invention is aimed at a cosmetic, non-therapeutic use, as an agent for preventing or treating the effects of atmospheric pollutants on the skin and / or integuments, of an extract of agrimony, in particular an extract of aerial parts. agrimony, more particularly flowering tops, said extract being in a cosmetic composition further comprising a cosmetically acceptable excipient.
- the invention thus relates to a non-therapeutic cosmetic use of an effective amount of an extract of agrimony, in particular an extract of aerial parts of agrimony, more particularly flowering tops, for preventing or treating the effects of atmospheric pollutants. on the skin and / or integuments.
- the effects of air pollutants on the skin can be selected from sagging skin, gray complexion, clogged pores, loss of radiance.
- the effects of atmospheric pollutants on the skin appendages can be chosen from dull hair, dry hair, brittle hair, oily hair.
- the invention also relates to the use of an extract of agrimony, in particular an extract of aerial parts of agrimony, more particularly the flowering tops, in a cosmetic composition, for preventing or treating the effects of atmospheric pollutants at the level of the skin and / or integuments.
- the invention relates to a composition or an extract according to the invention for its use to prevent or treat the effects of pollutants
- the invention is aimed at a method for preventing or treating the effects of atmospheric pollutants on the skin and / or integuments. comprising the topical application of a composition according to the invention.
- the invention relates to a method for preventing or treating the effects of atmospheric pollutants on the skin and / or integuments comprising the oral administration of a composition according to the invention.
- the invention also relates to the use of an extract according to the invention for the manufacture of a cosmetic or dermatological composition intended for the treatment or prevention of the effects of atmospheric pollutants on the skin and / or integuments.
- said cosmetic or dermatological composition is a composition suitable for topical application.
- said cosmetic or dermatological composition is a composition suitable for oral administration.
- the skin and / or integuments is skin or integuments exposed to an urban environment.
- an urban environment is particularly loaded with polluting agents and a skin or integuments thus exposed require a treatment such as that of the invention.
- the invention therefore also relates to a cosmetic method aimed at preventing or treating the effects of atmospheric pollutants on the skin and / or integuments of a person, in particular the skin of the face, said method comprising the topical application of a cosmetic composition comprising an extract of agrimony, in particular an extract of aerial parts of agrimony.
- the person to whom the cosmetic composition is applied is a person whose skin and / or integuments, in particular the skin of the face, is or are exposed to an urban environment.
- an extract of agrimony according to the invention in particular of its aerial parts, more particularly the flowering tops, exhibits a significant protective effect on human skin cells. , in particular the barrier layer, against several common air pollutants.
- an extract of agrimony according to the invention in particular of its aerial parts, more particularly the flowering tops, can be used for application to healthy skin subjected or which may be subjected to the influence. environmental aggressions such as climatic imbalances or pollutants and as such likely to cause skin discomfort or skin dryness.
- the extract of agrimony according to the invention, in particular of its aerial parts, more particularly the flowering tops can be applied to the skin when it already shows clinical signs of a deficiency of the skin barrier.
- extract of agrimony according to the invention in particular of its aerial parts, more particularly the flowering tops, to combat damage to the human skin barrier caused by environmental attacks.
- the present invention relates to an extract of agrimony according to the invention, in particular of its aerial parts, more particularly the flowering tops, for use in the treatment and / or prevention of disorders of the human skin barrier. and associated signs.
- the present invention relates to the use of agrimony extract according to the invention, in particular of its aerial parts, more particularly the flowering tops, for the preparation of a composition intended to fight against attacks of the human skin barrier caused by environmental attacks and / or to prevent and / or treat skin barrier disorders and associated signs.
- the present invention relates to a method for countering damage to the human skin barrier caused by attacks.
- the method comprising administering to the subject in need of an effective amount of agrimony extract according to the invention, in particular its aerial parts, more particularly the flowering tops.
- the present invention relates to a method for the treatment and / or prevention of disorders of the human skin barrier and associated signs, said method comprising administering to the subject in need of an effective amount of an extract.
- agrimony according to the invention in particular of its aerial parts, more particularly the flowering tops.
- Another aspect of the invention relates to a cosmetic composition or
- composition intended to fight against damage to the human skin barrier caused by environmental attacks, said composition comprising an effective amount of agrimony extract according to the invention, in particular of its aerial parts, more particularly the flowering tops, in a cosmetically or dermocosmetically acceptable medium.
- the extract of agrimony according to the invention offers protection against environmental attacks, in particular environmental attacks unrelated to UV, whether from the sun or from the sun. from man-made sources (including UVA and UVB rays), which can affect human skin barrier function and cause skin dryness.
- the agrimony extract according to the invention in particular of its aerial parts, more particularly the flowering tops, or one of its compositions according to the invention can in general be intended to improve the general condition of human skin, and in particular to counter environmental attacks and to prevent and / or treat disorders of the human skin barrier and the associated signs.
- an extract of agrimony according to the invention in particular of its aerial parts, more particularly the flowering tops, or one of its compositions is intended to prevent, treat and / or reduce the discomfort, the phenomena unpleasant or skin dryness of human skin subjected to the influence of environmental aggressions such as pollution, in particular environmental aggressions unrelated to UV.
- an extract of agrimony according to the invention in particular of its aerial parts, more particularly the flowering tops, or one of its compositions is intended to prevent, treat and / or improve a disorder of the human skin barrier and the associated signs, the skin barrier disorder being chosen from dry skin.
- Disorders of the human skin barrier and associated signs include all changes in the external appearance of the skin due in particular to the action of environmental attacks, in particular environmental attacks unrelated to UV rays, and to dehydration of the skin. skin (especially the epidermis), such as the rough and scaly appearance, and reduced flexibility, but also the skin sensations or discomfort caused, such as itching and / or tightness.
- An extract of agrimony according to the invention in particular of its aerial parts, more particularly the flowering tops, or one of its compositions according to the invention may in particular be intended for preventing, treating and / or improving skin dryness and / or skin disorders associated with a state of skin dryness, in particular dryness of an epidermis, and more particularly a lack of hydration of the horny layer.
- the genus Agrimonia includes 12 to 15 species, including the eupatory agrimony (Agrimonia eupatoria L.) which is a species of perennial nitrophilous, rhizomatous herbaceous plants, of the Rosaceae family, common throughout Europe.
- eupatory agrimony Agrimonia eupatoria L.
- Rosaceae family common throughout Europe.
- the fruits are hollowed out in strong furrows throughout their length and their hooked spines are not turned back.
- the fruit consists of 1 or 2 achenes enclosed in the bristling and persistent calyx whose throat has completely closed. It is a perennial plant, common in cool places, woods or wasteland.
- This species is not found on the mountains at great altitudes, common in general throughout France, it is found in all Europe except in the northern part of the Scandinavian peninsula and in the arctic regions, it is also found in the northern and western regions of Asia, North Africa, the Canary Islands.
- the plant is harvested throughout the summer, gathered into bouquets that are dried in the shade on racks or ropes.
- agrimony is used as a mild astringent internally and externally, used in pharyngitis, gastroenteritis and intestinal disorders.
- agrimony is used in cholecystopathies.
- the flowering tops are traditionally used in the symptomatic treatment of mild diarrhea (oral route), subjective manifestations of venous insufficiency (heavy legs) and in hemorrhoidal symptoms (oral and local route), mouthwashes for hygiene buccal.
- Agrimony contains phenolic compounds, volatile compounds and triterpene compounds.
- condensed tannins accompanied by small amounts of ellagitannins and traces of gallotannins in the stems, silica, flavonoids (luteolin, apigenin heterosides and kaempferol).
- the plant contains dimeric procyanidols (B-1, B-3, B-6, B-7), trimers (C-1, C-2, and others).
- Agrimony extract is intended to denote the product of extraction of all or part of the Agrimonia eupatoria plant, preferably its flowering tops.
- extraction product is meant the product obtained after extraction of aerial parts of the Agrimonia eupatoria plant, and in particular the flowering tops of Agrimonia eupatoria, with a solvent, called extraction solvent, (that is, ie a liquid solution in the extraction solvent) optionally in a concentrated or dry form after partial or total evaporation of the extraction solvent. It can therefore be a dry extract.
- extraction solvent that is, ie a liquid solution in the extraction solvent
- dry extract is intended to mean an extract free of extraction solvent or containing it only in the state of insignificant trace.
- a dry extract thus contains only material derived from Agrimonia eupatoria, in particular from its flowering tops. It may also contain insignificant traces of extraction solvent. It can be combined with a drying medium such as maltodextrins, starches, silicas ...
- the extract of Agrimonia eupatoria is advantageously obtained from the flowering tops of the plant.
- the parts of the agrimony plant in particular its flowering tops, can be fresh, frozen or dry, whole; cut or crushed then subjected to an extraction step.
- a method for preparing an extract according to the invention comprises a step of extracting Agrimonia eupatoria, in particular its flowering tops, with a solvent extraction.
- the extraction can be carried out at ambient temperature (for example between 15 and 30 ° C, in particular between 20 and 25 ° C) or hot (between 40 and 250 ° C and / or at atmospheric pressure or at high pressure.
- the extraction solvent can be a solvent chosen from:
- glycols for example propylene glycol, butylene glycol, pentylene glycol
- ketones including acetone and methyl ethyl acetone
- the extraction solvent is a hydro-alcoholic solvent, that is to say a mixture of C1 to C5 alcohol / water, such as an ethanol / water mixture.
- the solvent when it is hydroalcoholic, it may be a mixture of C1-C5 alcohol / water in an alcohol / water volume ratio of between 10/90 and 90/10, preferably between 20/80 and 40/60 .
- the extraction solvent is an ethanol / water mixture in a volume ratio of the order of 10/90 to 90/10, more particularly between 20/80 and 40/60. More particularly still, the extraction solvent is an ethanol / water mixture in a volume ratio of 30/70.
- the extraction can be carried out by various technologies, in particular “green” technologies, such as at atmospheric pressure (possibly using means of assistance for the extraction such as ultrasound, microwaves, leaching, maceration. , decoction ”) or at high pressures, with extraction solvents in the super- or sub-critical state such as C02 with or without co-solvent such as ethanol or water, and / or at temperatures between 20 ° C and 250 ° C.
- green technologies such as at atmospheric pressure (possibly using means of assistance for the extraction such as ultrasound, microwaves, leaching, maceration. , decoction ”) or at high pressures, with extraction solvents in the super- or sub-critical state such as C02 with or without co-solvent such as ethanol or water, and / or at temperatures between 20 ° C and 250 ° C.
- the solvent / parts of agrimony ratio can be between 1/5 and 1/20, particularly between 1/8 and 1/12, by mass (g) / volume (ml).
- the extract of agrimony in particular an extract of its flowering tops, will advantageously be composed of a phenolic fraction.
- phenolic fraction is meant a fraction of the extract containing compounds having one or more phenol groups such as flavonoids and tannins.
- the invention relates to the use of an extract of aerial part of agrimony as an anti-pollution cosmetic agent.
- anti-pollution cosmetic agent an ingredient of a cosmetic composition having the effect of preventing or treating the effects of atmospheric pollutants on the skin and / or integuments.
- the present invention relates to a composition
- dermatological or cosmetic comprising at least one extract of aerial part of agrimony with at least one dermatologically or cosmetically acceptable excipient for its use to prevent or treat the effects of atmospheric pollutants on the skin and / or integuments.
- integuments is understood to mean the hair, body hair, nails or any other keratin material. Preferably, it is the hair.
- the extract included in the dermatological or cosmetic composition is as described above.
- the dermatological or cosmetic composition comprising at least one extract of aerial part of agrimony as described above and at least one dermatologically or cosmetically acceptable excipient comprises from 0.01 to 10% by weight , preferably 0.05 to 5% by weight, more preferably 0.1 to 3% by weight, more preferably 0.5 to 2% extract of aerial parts of agrimony, by weight of dry extract relative to the total weight of the composition.
- the invention is preferably aimed at a dermatological or cosmetic composition according to the invention which is provided in a clean form and suitable for topical application, in particular to the skin, scalp and / or hair.
- the cosmetic or dermatological composition according to the invention can thus be provided in the forms which are usually known for topical administration, that is to say in particular lotions, shampoos, balms, foams, gels, dispersions. , emulsions, sprays, serums, masks or creams, with excipients capable in particular of penetration in order to improve the properties and accessibility of the active principle.
- it will be a milk, a cream or a balm.
- the invention is thus aimed at dermatological or cosmetic compositions according to one of the embodiments of the present invention, characterized in that they are provided in a clean form suitable for topical application.
- compositions generally contain, in addition to an extract of agrimony according to the invention, in particular an extract of aerial parts of agrimony, a physiologically acceptable medium, in particular one or more cosmetically or dermatologically acceptable excipients, generally based on water. or solvent, for example alcohols, ethers or glycols. They can thus also contain surfactants, complexing agents, preservatives, stabilizers, emulsifiers, thickeners, gelling agents, humectants, emollients, trace elements, essential oils, perfumes, dyes, mattifying agents, chemical or mineral filters, hydrating agents or thermal waters, anti-UV agents or sun filters, for example.
- the cosmetic or dermatological composition according to the invention may also contain at least one other anti-pollution compound chosen from sun filters,
- the present invention also relates to a composition
- a composition comprising an extract of aerial parts of agrimony as described, in a form suitable for oral administration.
- the invention thus relates to the use of an anti-polluting cosmetic composition according to the invention, characterized in that the composition is intended for oral administration.
- the invention relates to the use of an anti-polluting cosmetic composition comprising at least one extract of aerial parts of agrimony, with at least one pharmaceutically acceptable excipient, for preventing or treating the effects of atmospheric pollutants at the level of the skin and / or integuments characterized in that the composition is intended for oral administration.
- it may be a capsule, gelatin capsule, tablet or drinkable powder containing the extract of aerial parts of agrimony as described here in combination with usual pharmaceutically acceptable excipients such as bulking agents, stabilizers, coloring agents, traditionally used in the galenic formulation of oral pharmaceutical forms.
- oral forms may comprise 0.01 to 10% by weight, preferably 0.05 to 5% by weight, more preferably 0.1 to 3% by weight, more preferably 0.5 to 2%. extract of aerial parts of agrimony, by weight of dry extract relative to the total weight of the composition.
- the cosmetic or dermatological composition in a form suitable for topical application or oral administration, according to the invention, may also contain at least one other plant extract.
- the yield is 12 g / 100 g of flowering tops.
- the objective of this study is to evaluate the anti-oxidant, detoxifying and protective activity against ozone of an extract of agrimony, following exposure to ozone within a reconstructed human epithelium (RHE). thus mimicking the effect of pollution on the skin.
- RHE human epithelium
- Lipids playing a role in the barrier function of the epidermis can be impacted under stress conditions with increased oxidative damage to lipids.
- Direct measurements of lipid peroxidation can be performed by measuring malondialdhédyde (MD A) by gas chromatography techniques combined with mass spectrometry.
- MD A malondialdhédyde
- Trolox 3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1 -benzopyran-2-carboxylic acid, or Trolox, is a hydrophilic analogue of vitamin E. It is 'an antioxidant, which is used to limit damage due to oxidative stress.
- the agrimony extract is dissolved in water / DMSO, (80/20, v / v).
- the process is based on lipid oxidation from ozonolysis.
- Ozone production is carried out at 0.2 L / min by a mixture of 02 and 03 (99/1% (v / v)) in the medium.
- the production of 1% ozone produced by this process is equivalent to 4 ppm of exposure to ozone.
- the ozonolysis reaction induces various products called primary or secondary products according to the Criegee rearrangement.
- RHEs are constructed from normal human primary keratinocytes obtained from subjects who have undergone abdominal dermolipectomy. After 8 days of exposure to air, the medium is changed, the test compound is added to the desired concentration. On day 9, the RHEs are placed in a chamber with a new medium. The reaction medium is cooled to 5 ° C. and under bubbled air for 1 minute. The air production is 0.2 L / min at
- the RHEs are introduced into a plate and a new medium (without active ingredient) is added. On day 10, the RHE and media are recovered.
- a protection index is calculated from the stress and control conditions.
- IP (%) (stress condition - (stress condition + active)) / (stress condition - control condition) * 100.
- the statistical evaluation is based on a one-way ANOVA followed by the Bonferroni multiple comparison test.
- MDA ng / mg of protein
- the inventors demonstrate that an extract of agrimony induces a protective effect against lipid peroxidation due to ozone, demonstrating an anti-pollution effect.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1904763A FR3095760B1 (fr) | 2019-05-07 | 2019-05-07 | Extrait d’aigremoine comme agent anti-pollution |
PCT/EP2020/062606 WO2020225318A1 (fr) | 2019-05-07 | 2020-05-06 | Extrait d'aigremoine comme agent anti-pollution |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3965728A1 true EP3965728A1 (de) | 2022-03-16 |
Family
ID=67660314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20722610.1A Pending EP3965728A1 (de) | 2019-05-07 | 2020-05-06 | Odermennigextrakt als umweltfreundliches mittel |
Country Status (8)
Country | Link |
---|---|
US (1) | US20220226231A1 (de) |
EP (1) | EP3965728A1 (de) |
JP (1) | JP2022532559A (de) |
KR (1) | KR20220005505A (de) |
CN (1) | CN114025740A (de) |
FR (1) | FR3095760B1 (de) |
MX (1) | MX2021013455A (de) |
WO (1) | WO2020225318A1 (de) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2838342B1 (fr) | 2002-04-10 | 2005-06-17 | Gelyma | Compositions cosmetiques ou dermopharmaceutiques renfermant un extrait de macroalgue marine comme principe actif anti-oxydant et/ou anti-pollution |
FR2884718B1 (fr) | 2005-04-22 | 2007-06-22 | Clarins Soc Par Actions Simpli | Composition cosmetique pour lutter contre les consequences cutanees de la pollution |
CN101766555A (zh) * | 2008-12-31 | 2010-07-07 | 云南恒冠实业有限公司 | 一种抗衰老、去皱抗皱化妆品组合物 |
CN102743313B (zh) * | 2012-07-27 | 2013-06-05 | 王恩瀚 | 具有延缓皮肤衰老作用的天然药物组合物及其用途 |
CN104107154A (zh) * | 2014-07-30 | 2014-10-22 | 广州丹奇日用化工厂有限公司 | 一种化妆品组合物及其制备方法 |
CN104434628B (zh) * | 2014-11-11 | 2017-07-14 | 广东幸美化妆品股份有限公司 | 一种48小时持续补水的水份霜膜及其制备方法 |
CN104856901B (zh) * | 2015-05-20 | 2018-09-21 | 广东幸美化妆品股份有限公司 | 一种八倍水保湿焕颜面膜及其制备方法 |
CN108815034A (zh) * | 2018-07-29 | 2018-11-16 | 佛山文森特知识产权服务有限公司 | 一种细致毛孔的化妆品组合物 |
-
2019
- 2019-05-07 FR FR1904763A patent/FR3095760B1/fr active Active
-
2020
- 2020-05-06 CN CN202080045784.3A patent/CN114025740A/zh active Pending
- 2020-05-06 EP EP20722610.1A patent/EP3965728A1/de active Pending
- 2020-05-06 KR KR1020217038126A patent/KR20220005505A/ko unknown
- 2020-05-06 JP JP2021566155A patent/JP2022532559A/ja active Pending
- 2020-05-06 MX MX2021013455A patent/MX2021013455A/es unknown
- 2020-05-06 US US17/609,161 patent/US20220226231A1/en active Pending
- 2020-05-06 WO PCT/EP2020/062606 patent/WO2020225318A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
FR3095760B1 (fr) | 2022-05-13 |
US20220226231A1 (en) | 2022-07-21 |
KR20220005505A (ko) | 2022-01-13 |
WO2020225318A1 (fr) | 2020-11-12 |
CN114025740A (zh) | 2022-02-08 |
FR3095760A1 (fr) | 2020-11-13 |
MX2021013455A (es) | 2022-01-24 |
JP2022532559A (ja) | 2022-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3393444B1 (de) | Passionsblumen-extrakt und kosmetischen, pharmazeutischen oder dermatologischen zusammensetzungen, die diese umfassen. | |
FR2676649A1 (fr) | Composition cosmetique ou pharmaceutique, notamment dermatologique, destinee a favoriser la pigmentation de la peau ou des cheveux, contenant un extrait de cyperus et son procede de fabrication. | |
EP4099975A1 (de) | Verfahren zur herstellung eines wässrigen lavendelextraktes, zusammensetzungen mit einem solchen extrakt und deren kosmetische verwendungen | |
EP3280497A1 (de) | Hydroalkoholisches extrakt aus schinus molle, kosmetische zusammensetzungen damit und kosmetische verwendungen davon | |
EP2691074A1 (de) | Zusammensetzung auf der basis von camellia japonica und polygonum hydropiper zum schutz der haut | |
KR101736714B1 (ko) | 천연 추출물을 포함하는 피부 개선용 화장료 조성물 | |
CA3173694C (fr) | Extrait de graines de moringa peregrina riche en 2,5-diformylfuran, son procede d'obtention et son utilisation dans des compositions cosmetiques | |
WO2020008151A1 (fr) | Composition huileuse contenant un extrait de mimosa tenuiflora et utilisations | |
FR2677248A1 (fr) | Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant un extrait de brunelle. | |
WO2020225319A1 (fr) | Extrait d'aigremoine comme agent anti-pollution | |
FR3097762A1 (fr) | Utilisation d'un extrait hydro-alcoolique d'Onagre pour hydrater la peau et améliorer la fonction barrière | |
WO1993004667A1 (fr) | Composition cosmetique ou pharmaceutique contenant un extrait de coleus esquirolii, de coleus scutellarioides ou de coleus xanthanthus | |
FR3023482A1 (fr) | Extrait hydroglycerine d'ombellifere pour un usage cosmetique | |
WO2020225318A1 (fr) | Extrait d'aigremoine comme agent anti-pollution | |
WO2009138583A2 (fr) | Utilisation d'une composition contenant de l'ergosterol ou un extrait naturel de micro-organisme ou vegetal ou animal | |
KR101736716B1 (ko) | 식물 추출물을 포함하는 피부 탄력 및 주름 개선용 화장료 조성물 | |
EP3052198A1 (de) | Ölige zusammensetzung mit einem taglilienextrakt und verwendungen davon | |
EP2811978B1 (de) | Verwendung eines extraktes aus der apfelbaumrinde zur kosmetischen verhinderung von alterserscheinungnen der haut | |
FR3110419A1 (fr) | Extrait de graines de Moringa peregrina riche en 2,5-diformylfuran, son procédé d’obtention et son utilisation dans des compositions cosmétiques | |
FR3034015A1 (fr) | Composition comprenant des fleurs sechees d'immortelle pour un usage cosmetique | |
WO2024018160A1 (fr) | Extrait anhydre de feuilles sans tige d'hippophae rhamnoides ou composition comprenant ledit extrait pour utilisation pour maintenir et/ou ameliorer la microcirculation cutanee | |
FR3001891A1 (fr) | Association d'un extrait de crocus sativus l. et d'huile de pistacia vera l. utilisables en cosmetique | |
OA21067A (fr) | Extrait de graines de Moringa Peregrina riche en 2,5-diformylfuran, son procédé d'obtention et son utilisation dans des compositions cosmétiques. | |
FR2953725A1 (fr) | Procede pour obtenir un extrait standardise de quercetine et de 3-o-methylquercetine a partir d'inflorescences de macela-do-campo, et composition cosmetique, pharmaceutique et veterinaire le contenant | |
WO2012172200A1 (fr) | Composition a base de samanea saman pour la protection de la peau |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20211206 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20230321 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230516 |
|
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: PIERRE FABRE DERMO-COSMETIQUE |